AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22749817 — intervention group
Group type: EXPERIMENTAL
Intervention: HIFU ablation with 1 mL of iodized oil
Number of subjects: 40
Study 22749817 — intervention group
Group type: COMPARATOR
Intervention: HIFU ablation with physiologic saline
Number of subjects: 40
Study 22749817 — intervention group
Group type: EXPERIMENTAL
Intervention: HIFU ablation with iodized oil
Number of subjects: 40
Study 19648462 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep deprivation
Number of subjects: 0
Study 16798012 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam
Number of subjects: 0
Study 16798012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 15176682 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP)
Number of subjects: 613
Study 15176682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 613
Study 14597886 — intervention group
Group type: EXPERIMENTAL
Intervention: Revascularization and ventricular restoration procedures
Number of subjects: 0
Study 14597886 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting
Number of subjects: 0
Study 14597886 — intervention group
Group type: EXPERIMENTAL
Intervention: Nuclear medicine studies and stress echocardiography
Number of subjects: 0
Study 14597886 — intervention group
Group type: EXPERIMENTAL
Intervention: Combining ventricular restoration with bypass surgery
Number of subjects: 0
Study 10360854 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (0.75 mg/kg for verbal command response)
Number of subjects: 180
Study 10360854 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (1.28 mg/kg for tetanic stimulus response)
Number of subjects: 180
Study 10360854 — intervention group
Group type: COMPARATOR
Intervention: Propofol (1.01 mg/kg for verbal command response)
Number of subjects: 180
Study 10360854 — intervention group
Group type: COMPARATOR
Intervention: Propofol (1.76 mg/kg for tetanic stimulus response)
Number of subjects: 180
Study 10360854 — intervention group
Group type: COMPARATOR
Intervention: Propofol (0.98 mg/kg for verbal command response)
Number of subjects: 180
Study 10360854 — intervention group
Group type: COMPARATOR
Intervention: Propofol (1.89 mg/kg for tetanic stimulus response)
Number of subjects: 180
Study 7531845 — intervention group
Group type: EXPERIMENTAL
Intervention: AgNOR counting method 1
Number of subjects: 50
Study 7531845 — intervention group
Group type: EXPERIMENTAL
Intervention: AgNOR counting method 2
Number of subjects: 50
Study 7531845 — intervention group
Group type: EXPERIMENTAL
Intervention: AgNOR counting method 3
Number of subjects: 50
Study 7531845 — intervention group
Group type: EXPERIMENTAL
Intervention: Replicate counts
Number of subjects: 50
Study 7531845 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall AgNOR counts
Number of subjects: 50
Study 7531845 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical standardization
Number of subjects: 50
Study 7531845 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproducibility
Number of subjects: 50
Study 7531845 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with prognosis
Number of subjects: 50
Study 1826213 — intervention group
Group type: EXPERIMENTAL
Intervention: celiprolol 400 mg/day
Number of subjects: 46
Study 1826213 — intervention group
Group type: COMPARATOR
Intervention: atenolol 100 mg/day
Number of subjects: 46
Study 6411939 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic treatment
Number of subjects: 90
Study 6411939 — intervention group
Group type: COMPARATOR
Intervention: Conventional followup (Control)
Number of subjects: 90
Study 6411939 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 90
Study 29908371 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended-sensor (MV + XL) programming
Number of subjects: 501
Study 29908371 — intervention group
Group type: COMPARATOR
Intervention: Accelerometer (XL) alone
Number of subjects: 501
Study 27163699 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation (2.0 g, 3 times per day for 14 days)
Number of subjects: 29
Study 27163699 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2.0 g, 3 times per day for 14 days)
Number of subjects: 29
Study 25073446 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-Oss
Number of subjects: 155
Study 25073446 — intervention group
Group type: EXPERIMENTAL
Intervention: NanoBone
Number of subjects: 155
Study 25073446 — intervention group
Group type: EXPERIMENTAL
Intervention: easy-graft CLASSIC
Number of subjects: 155
Study 25073446 — intervention group
Group type: EXPERIMENTAL
Intervention: easy-graft CRYSTAL
Number of subjects: 155
Study 25073446 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 155
Study 23032585 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine injection
Number of subjects: 10
Study 23032585 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution) injection
Number of subjects: 10
Study 20232131 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal digital assistant-based dietary self-monitoring
Number of subjects: 123
Study 17416765 — intervention group
Group type: EXPERIMENTAL
Intervention: Oophorectomy
Number of subjects: 1601
Study 17416765 — intervention group
Group type: COMPARATOR
Intervention: Natural menopause
Number of subjects: 1601
Study 17416765 — intervention group
Group type: COMPARATOR
Intervention: Age at menopause
Number of subjects: 1601
Study 17416765 — intervention group
Group type: COMPARATOR
Intervention: Age at menarche
Number of subjects: 1601
Study 17416765 — intervention group
Group type: COMPARATOR
Intervention: Total duration of breast mitotic activity
Number of subjects: 1601
Study 16091268 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary processing in strategy change
Number of subjects: 2
Study 16091268 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary decision-making against adopting a new strategy
Number of subjects: 2
Study 12190218 — intervention group
Group type: EXPERIMENTAL
Intervention: Helicobacter pylori eradication treatment
Number of subjects: 8
Study 12190218 — intervention group
Group type: COMPARATOR
Intervention: Uninfected diabetic children (control group)
Number of subjects: 8
Study 9584539 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention (psychiatric evaluation plus 1 to 7 sessions of behavioral therapy)
Number of subjects: 380
Study 9584539 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 380
Study 9584539 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychologically treated patients (special intervention)
Number of subjects: 380
Study 9584539 — intervention group
Group type: COMPARATOR
Intervention: Untreated patients (usual care)
Number of subjects: 380
Study 9584539 — intervention group
Group type: EXPERIMENTAL
Intervention: Special intervention
Number of subjects: 380
Study 8597462 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEAS
Number of subjects: 0
Study 2759361 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of 300 ml of water to a meal
Number of subjects: 27
Study 1165338 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed Feedback
Number of subjects: 48
Study 1165338 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed Feedback with LOA
Number of subjects: 48
Study 1165338 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Feedback
Number of subjects: 48
Study 1165338 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Feedback with LOA
Number of subjects: 48
Study 1165338 — intervention group
Group type: COMPARATOR
Intervention: No Feedback
Number of subjects: 48
Study 1165338 — intervention group
Group type: COMPARATOR
Intervention: No Feedback with LOA
Number of subjects: 48
Study 29908359 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg daily (n = 72)
Number of subjects: 147
Study 29908359 — intervention group
Group type: COMPARATOR
Intervention: placebo (n = 75)
Number of subjects: 147
Study 28586279 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib (600 mg twice daily)
Number of subjects: 303
Study 28586279 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib (250 mg twice daily)
Number of subjects: 303
Study 28586279 — intervention group
Group type: EXPERIMENTAL
Intervention: Alectinib
Number of subjects: 303
Study 28586279 — intervention group
Group type: COMPARATOR
Intervention: Crizotinib
Number of subjects: 303
Study 25565482 — intervention group
Group type: EXPERIMENTAL
Intervention: health‐promotion intervention
Number of subjects: 1181
Study 25565482 — intervention group
Group type: COMPARATOR
Intervention: attention‐matched control intervention
Number of subjects: 1181
Study 24171979 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemocoagulase solution
Number of subjects: 20
Study 24171979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 21062083 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitosomal daunorubicin plus amlodipine
Number of subjects: 0
Study 19484759 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (PIP/TAZO) 80 mg/kg piperacillin/10 mg/kg tazobactam every 6 hr
Number of subjects: 70
Study 19484759 — intervention group
Group type: COMPARATOR
Intervention: Cefepime (CEF) 50 mg/kg every 8 hr
Number of subjects: 70
Study 17121552 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% lidocaine (2.0 mg.kg(‐1))
Number of subjects: 358
Study 14631221 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (10 minutes of ischemia followed by 10 minutes of reperfusion)
Number of subjects: 100
Study 14631221 — intervention group
Group type: COMPARATOR
Intervention: Control (no ischemic preconditioning)
Number of subjects: 100
Study 10989266 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA (1.5 mg/kg p.o.) with ketanserin (50 mg p.o.)
Number of subjects: 14
Study 10989266 — intervention group
Group type: COMPARATOR
Intervention: MDMA (1.5 mg/kg p.o.) alone
Number of subjects: 14
Study 9077073 — intervention group
Group type: EXPERIMENTAL
Intervention: LTB*-combined vaccine
Number of subjects: 32
Study 9077073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 7524759 — intervention group
Group type: COMPARATOR
Intervention: 30 micrograms of recombinant G-CSF per day
Number of subjects: 38
Study 7524759 — intervention group
Group type: COMPARATOR
Intervention: 300 micrograms of recombinant G-CSF per day
Number of subjects: 38
Study 2884855 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin, administered once daily
Number of subjects: 104
Study 2884855 — intervention group
Group type: COMPARATOR
Intervention: Prazosin, administered twice daily
Number of subjects: 104
Study 2884855 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxazosin
Number of subjects: 104
Study 2884855 — intervention group
Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 104
Study 2884855 — intervention group
Group type: COMPARATOR
Intervention: Doxazosin and Prazosin
Number of subjects: 104
Study 31782167 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified four-session Comprehensive Behavioral Intervention for Tics
Number of subjects: 46
Study 31782167 — intervention group
Group type: COMPARATOR
Intervention: Routine care (daily pyridoxine [50 mg] and psychoeducation)
Number of subjects: 46
Study 31782167 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified four-session Comprehensive Behavioral Intervention for Tics (3-month follow-up)
Number of subjects: 46
Study 30307986 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient controlled remifentanil
Number of subjects: 1358
Study 30307986 — intervention group
Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 1358
Study 28608739 — intervention group
Group type: EXPERIMENTAL
Intervention: AM-101 0.87 mg/mL
Number of subjects: 343
Study 28608739 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 343
Study 27807526 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Exercise Group (SEG)
Number of subjects: 36
Study 27807526 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Exercise Group (CEG)
Number of subjects: 36
Study 27807526 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 36
Study 23519139 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor IX Complex (mean dose 35 units/kg)
Number of subjects: 11
Study 21084137 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral osteoarthrectomy and condylar reconstruction by free grafting of autogenous coronoid process with three‐dimensional simulation using Surgicase CMF™ software
Number of subjects: 16
Study 21084137 — intervention group
Group type: COMPARATOR
Intervention: Bilateral osteoarthrectomy and condylar reconstruction by free grafting of autogenous coronoid process without three‐dimensional simulation
Number of subjects: 16
Study 19544758 — intervention group
Group type: EXPERIMENTAL
Intervention: Online treatment
Number of subjects: 118
Study 19544758 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 118
Study 17144489 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved UPPP
Number of subjects: 85
Study 17144489 — intervention group
Group type: COMPARATOR
Intervention: Traditional UPPP
Number of subjects: 85
Study 15265377 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg daily for 12 months)
Number of subjects: 204
Study 15265377 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 11475793 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 0
Study 11475793 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 9254982 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resolution electrocardiogram (HRECG) measuring abnormal intra-QRS potentials (AIQP)
Number of subjects: 0
Study 8217239 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (50 Gy/5 weeks + 10-20 Gy boost)
Number of subjects: 59
Study 8217239 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy with weekly 5-FU (600 mg/m2)
Number of subjects: 59
Study 3304622 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (group 1)
Number of subjects: 24
Study 3304622 — intervention group
Group type: COMPARATOR
Intervention: No treatment (group 2)
Number of subjects: 24
Study 30486573 — intervention group
Group type: EXPERIMENTAL
Intervention: GERD patients with extra-esophageal symptoms
Number of subjects: 60
Study 26933811 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose tacrolimus (0.04-0.05 mg/kg/day) + donor-derived mesenchymal stem cells (MSCs)
Number of subjects: 16
Study 26933811 — intervention group
Group type: COMPARATOR
Intervention: Standard dose tacrolimus (0.07-0.08 mg/kg/day)
Number of subjects: 16
Study 26933811 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose tacrolimus + MSCs
Number of subjects: 16
Study 26933811 — intervention group
Group type: COMPARATOR
Intervention: Standard dose tacrolimus
Number of subjects: 16
Study 24935932 — intervention group
Group type: EXPERIMENTAL
Intervention: DPP4 inhibitor sitagliptin
Number of subjects: 10
Study 21825083 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-809 100 mg
Number of subjects: 89
Study 21825083 — intervention group
Group type: EXPERIMENTAL
Intervention: VX-809 200 mg
Number of subjects: 89
Study 21825083 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study 20652790 — intervention group
Group type: EXPERIMENTAL
Intervention: One-visit root canal therapy (ORCT)
Number of subjects: 407
Study 20652790 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpotomy with calcium-enriched mixture cement (PCEM)
Number of subjects: 407
Study 20652790 — intervention group
Group type: COMPARATOR
Intervention: Comparison of mean PI sum over 7 days
Number of subjects: 407
Study 20652790 — intervention group
Group type: COMPARATOR
Intervention: Pain in response to percussion tests
Number of subjects: 407
Study 18523884 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat treatment at 40 degrees C for 2 hours
Number of subjects: 197
Study 18523884 — intervention group
Group type: COMPARATOR
Intervention: Control group incubated at 37 degrees C
Number of subjects: 197
Study 15853214 — intervention group
Group type: EXPERIMENTAL
Intervention: YM 294 (rhlL-11) at a dose of 50 microg/kg
Number of subjects: 0
Study 15853214 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment observation group
Number of subjects: 0
Study 12544528 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled hemorrhoidectomy
Number of subjects: 60
Study 12544528 — intervention group
Group type: COMPARATOR
Intervention: Diathermy hemorrhoidectomy
Number of subjects: 60
Study 12544528 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 60
Study 11083035 — intervention group
Group type: EXPERIMENTAL
Intervention: Training programme for physicians
Number of subjects: 20
Study 11083035 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 20
Study 8864421 — intervention group
Group type: EXPERIMENTAL
Intervention: ANP (10 ng kg‐1 min‐1) during ANG II infusion
Number of subjects: 69
Study 8864421 — intervention group
Group type: EXPERIMENTAL
Intervention: ANP (10 ng kg‐1 min‐1) during NA infusion
Number of subjects: 69
Study 8864421 — intervention group
Group type: COMPARATOR
Intervention: ANG II alone
Number of subjects: 69
Study 8864421 — intervention group
Group type: COMPARATOR
Intervention: NA alone
Number of subjects: 69
Study 8864421 — intervention group
Group type: COMPARATOR
Intervention: ANP alone
Number of subjects: 69
Study 7689971 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg/day
Number of subjects: 69
Study 7689971 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 10 mg/day
Number of subjects: 69
Study 7689971 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study 7689971 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg/day (3 years therapy)
Number of subjects: 69
Study 3780288 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg diazepam in conventional tablet form on the morning of operation
Number of subjects: 60
Study 3780288 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release diazepam the night before surgery
Number of subjects: 60
Study 3780288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 30988972 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy-enhancing intervention (SEEI)
Number of subjects: 90
Study 30988972 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard prenatal care)
Number of subjects: 90
Study 27287784 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial day care programme
Number of subjects: 100
Study 27287784 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard pharmacotherapy)
Number of subjects: 100
Study 23984947 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillatory synchronization in distinct frequency-coupled networks
Number of subjects: 0
Study 23984947 — intervention group
Group type: COMPARATOR
Intervention: Local oscillations or ERPs
Number of subjects: 0
Study 22699824 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 2536 200 mg on day 1
Number of subjects: 86
Study 22699824 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 2536 60 mg on days 1-3
Number of subjects: 86
Study 22699824 — intervention group
Group type: EXPERIMENTAL
Intervention: BI 2536 (both dosages)
Number of subjects: 86
Study 20675950 — intervention group
Group type: EXPERIMENTAL
Intervention: Familias Sanas (Healthy Families) educational intervention
Number of subjects: 0
Study 20675950 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 18584516 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 177
Study 18584516 — intervention group
Group type: COMPARATOR
Intervention: Conventional Nissen fundoplication (CNF)
Number of subjects: 177
Study 15686241 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal femoral nail (n = 42)
Number of subjects: 108
Study 15686241 — intervention group
Group type: COMPARATOR
Intervention: Dynamic hip screw (n = 41)
Number of subjects: 108
Study 15686241 — intervention group
Group type: COMPARATOR
Intervention: Dynamic hip screw
Number of subjects: 108
Study 15686241 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal femoral nail
Number of subjects: 108
Study 15686241 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 108
Study 12883194 — intervention group
Group type: COMPARATOR
Intervention: SRL‐CsA‐ST group
Number of subjects: 525
Study 12883194 — intervention group
Group type: EXPERIMENTAL
Intervention: SRL‐ST group
Number of subjects: 525
Study 9888075 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonpreserved ketorolac tromethamine 0.5% ophthalmic solution, 4 times daily for 3 days or until no ocular pain
Number of subjects: 170
Study 9888075 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 170
Study 8652323 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 1.0 mg
Number of subjects: 527
Study 8652323 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3.0 mg
Number of subjects: 527
Study 8652323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 527
Study 1799355 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 0
Study 1799355 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6365881 — intervention group
Group type: EXPERIMENTAL
Intervention: Netilmicin-ticarcillin
Number of subjects: 80
Study 6365881 — intervention group
Group type: COMPARATOR
Intervention: Tobramycin-ticarcillin
Number of subjects: 80
Study 31322974 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-mA tRNS
Number of subjects: 72
Study 31322974 — intervention group
Group type: COMPARATOR
Intervention: 2-mA tRNS
Number of subjects: 72
Study 31322974 — intervention group
Group type: COMPARATOR
Intervention: Sham tRNS
Number of subjects: 72
Study 30058901 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 0
Study 30058901 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 27257981 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose intraarticular injection of 4 ml lightly cross‐linking sodium hyaluronate (Monovisc)
Number of subjects: 40